Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Spike Glycoprotein, Coronavirus"" wg kryterium: Wszystkie pola

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 2209
Tytuł:
Disappearance of Imported Cases of Omicron Lineage BA.2.40 in West Kalimantan, Indonesia.
Autorzy:
Liana DF; Department of Microbiology, School of Medicine, Universitas Tanjungpura, Pontianak, Indonesia.
Novianry V; Department of Biochemistry and Biomolecular, School of Medicine, Universitas Tanjungpura, Pontianak, Indonesia.
Andriani A; Department of Biochemistry and Biomolecular, School of Medicine, Universitas Tanjungpura, Pontianak, Indonesia.
Mahyarudin M; Department of Microbiology, School of Medicine, Universitas Tanjungpura, Pontianak, Indonesia.
Astuti P; Department of Biochemistry and Biomolecular, School of Medicine, Universitas Tanjungpura, Pontianak, Indonesia.
Pokaż więcej
Źródło:
Iranian journal of medical sciences [Iran J Med Sci] 2024 Mar 01; Vol. 49 (3), pp. 176-185. Date of Electronic Publication: 2024 Mar 01 (Print Publication: 2024).
Typ publikacji:
Journal Article
MeSH Terms:
Spike Glycoprotein, Coronavirus*/genetics
COVID-19*
Humans ; Indonesia/epidemiology ; Phylogeny ; Biological Evolution ; SARS-CoV-2/genetics
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Three-Dimensional Structural Stability and Local Electrostatic Potential at Point Mutations in Spike Protein of SARS-CoV-2 Coronavirus.
Autorzy:
Hristova SH; Department of Medical Physics and Biophysics, Medical Faculty, Medical University-Sofia, Zdrave Street 2, 1431 Sofia, Bulgaria.
Zhivkov AM; Scientific Research Center, 'St. Kliment Ohridski' Sofia University, 8 Dragan Tsankov Blvd., 1164 Sofia, Bulgaria.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2024 Feb 11; Vol. 25 (4). Date of Electronic Publication: 2024 Feb 11.
Typ publikacji:
Journal Article
MeSH Terms:
COVID-19*
Point Mutation*
Spike Glycoprotein, Coronavirus*/genetics
Spike Glycoprotein, Coronavirus*/physiology
Humans ; Amino Acids ; Angiotensin-Converting Enzyme 2 ; Mutation ; Protein Binding ; SARS-CoV-2/genetics ; Static Electricity
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Peak transgene expression after intramuscular immunization of mice with adenovirus 26-based vector vaccines correlates with transgene-specific adaptive immune responses.
Autorzy:
Marquez-Martinez S; Janssen Vaccines & Prevention B.V, Leiden, CN, The Netherlands.
Salisch N; Janssen Vaccines & Prevention B.V, Leiden, CN, The Netherlands.
Serroyen J; Janssen Vaccines & Prevention B.V, Leiden, CN, The Netherlands.
Zahn R; Janssen Vaccines & Prevention B.V, Leiden, CN, The Netherlands.
Khan S; Janssen Vaccines & Prevention B.V, Leiden, CN, The Netherlands.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2024 Apr 16; Vol. 19 (4), pp. e0299215. Date of Electronic Publication: 2024 Apr 16 (Print Publication: 2024).
Typ publikacji:
Journal Article
MeSH Terms:
Adenovirus Vaccines*
Vaccines*
Spike Glycoprotein, Coronavirus*
Animals ; Mice ; Humans ; Immunity, Humoral ; Tissue Distribution ; Immunization ; Vaccination ; Adenoviridae/genetics ; Transgenes ; Genetic Vectors/genetics ; Antibodies, Viral
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Expression of the SARS-CoV-2 receptor-binding domain by live attenuated influenza vaccine virus as a strategy for designing a bivalent vaccine against COVID-19 and influenza.
Autorzy:
Stepanova E; Institute of Experimental Medicine, Saint Petersburg, 197022, Russia. .
Isakova-Sivak I; Institute of Experimental Medicine, Saint Petersburg, 197022, Russia.
Mezhenskaya D; Institute of Experimental Medicine, Saint Petersburg, 197022, Russia.
Niskanen S; Joint-Stock Company «BIOCAD» (JSC «BIOCAD») Saint Petersburg, Intracity Municipality the Settlement of Strelna, the Settlement of Strelna, ul. Svyazi, d. 38, str. 1, pomeshch. 89, Saint Petersburg, 198515, Russia.
Matyushenko V; Institute of Experimental Medicine, Saint Petersburg, 197022, Russia.
Bazhenova E; Institute of Experimental Medicine, Saint Petersburg, 197022, Russia.
Rak A; Institute of Experimental Medicine, Saint Petersburg, 197022, Russia.
Wong PF; Institute of Experimental Medicine, Saint Petersburg, 197022, Russia.
Prokopenko P; Institute of Experimental Medicine, Saint Petersburg, 197022, Russia.
Kotomina T; Institute of Experimental Medicine, Saint Petersburg, 197022, Russia.
Krutikova E; Institute of Experimental Medicine, Saint Petersburg, 197022, Russia.
Legotskiy S; Joint-Stock Company «BIOCAD» (JSC «BIOCAD») Saint Petersburg, Intracity Municipality the Settlement of Strelna, the Settlement of Strelna, ul. Svyazi, d. 38, str. 1, pomeshch. 89, Saint Petersburg, 198515, Russia.
Neterebskii B; Joint-Stock Company «BIOCAD» (JSC «BIOCAD») Saint Petersburg, Intracity Municipality the Settlement of Strelna, the Settlement of Strelna, ul. Svyazi, d. 38, str. 1, pomeshch. 89, Saint Petersburg, 198515, Russia.
Ostroukhova T; Joint-Stock Company «BIOCAD» (JSC «BIOCAD») Saint Petersburg, Intracity Municipality the Settlement of Strelna, the Settlement of Strelna, ul. Svyazi, d. 38, str. 1, pomeshch. 89, Saint Petersburg, 198515, Russia.
Sivak K; Smorodintsev Research Institute of Influenza, Saint Petersburg, 197376, Russia.
Orshanskaya Y; Smorodintsev Research Institute of Influenza, Saint Petersburg, 197376, Russia.
Yakovlev K; Smorodintsev Research Institute of Influenza, Saint Petersburg, 197376, Russia.
Rudenko L; Institute of Experimental Medicine, Saint Petersburg, 197022, Russia.
Pokaż więcej
Źródło:
Virology journal [Virol J] 2024 Apr 09; Vol. 21 (1), pp. 82. Date of Electronic Publication: 2024 Apr 09.
Typ publikacji:
Journal Article
MeSH Terms:
Influenza, Human*
Influenza Vaccines*/genetics
COVID-19*
Spike Glycoprotein, Coronavirus*
Humans ; Animals ; Mice ; SARS-CoV-2/genetics ; COVID-19 Vaccines ; Vaccines, Combined ; Antibodies, Viral ; Hemagglutinins
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
An Approach for Engineering Peptides for Competitive Inhibition of the SARS-COV-2 Spike Protein.
Autorzy:
de Abreu AP; Laboratory of Bioinformatics and Systems, Department of Computer Science, Institute of Exact Sciences, Universidade Federal de Minas Gerais, Belo Horizonte 31270-901, Brazil.
Carvalho FC; Laboratory of Bioinformatics and Systems, Department of Computer Science, Institute of Exact Sciences, Universidade Federal de Minas Gerais, Belo Horizonte 31270-901, Brazil.
Mariano D; Laboratory of Bioinformatics and Systems, Department of Computer Science, Institute of Exact Sciences, Universidade Federal de Minas Gerais, Belo Horizonte 31270-901, Brazil.
Bastos LL; Laboratory of Bioinformatics and Systems, Department of Computer Science, Institute of Exact Sciences, Universidade Federal de Minas Gerais, Belo Horizonte 31270-901, Brazil.
Silva JRP; Department of Biochemistry and Immunology, Institute of Biological Sciences, Universidade Federal de Minas Gerais, Belo Horizonte 31270-901, Brazil.
de Oliveira LM; Laboratory of Bioinformatics and Systems, Department of Computer Science, Institute of Exact Sciences, Universidade Federal de Minas Gerais, Belo Horizonte 31270-901, Brazil.
de Melo-Minardi RC; Laboratory of Bioinformatics and Systems, Department of Computer Science, Institute of Exact Sciences, Universidade Federal de Minas Gerais, Belo Horizonte 31270-901, Brazil.
Sabino AP; Laboratory of Clinical and Experimental Hematology, Clinical and Toxicological Analysis Department, Faculty of Pharmacy, Universidade Federal de Minas Gerais, Belo Horizonte 31270-901, Brazil.
Pokaż więcej
Źródło:
Molecules (Basel, Switzerland) [Molecules] 2024 Apr 01; Vol. 29 (7). Date of Electronic Publication: 2024 Apr 01.
Typ publikacji:
Journal Article
MeSH Terms:
Spike Glycoprotein, Coronavirus*
COVID-19*
Humans ; SARS-CoV-2 ; Peptides/pharmacology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Plant virus-derived nanoparticles decorated with genetically encoded SARS-CoV-2 nanobodies display enhanced neutralizing activity.
Autorzy:
Merwaiss F; Instituto de Biología Molecular y Celular de Plantas, Consejo Superior de Investigaciones Científicas - Universitat Politècnica de València, Valencia, Spain.
Lozano-Sanchez E; Instituto de Biología Molecular y Celular de Plantas, Consejo Superior de Investigaciones Científicas - Universitat Politècnica de València, Valencia, Spain.
Zulaica J; Institute for Integrative Systems Biology, Consejo Superior de Investigaciones Científicas - Universitat de València, Paterna, Spain.
Rusu L; Institute for Integrative Systems Biology, Consejo Superior de Investigaciones Científicas - Universitat de València, Paterna, Spain.
Vazquez-Vilar M; Instituto de Biología Molecular y Celular de Plantas, Consejo Superior de Investigaciones Científicas - Universitat Politècnica de València, Valencia, Spain.
Orzáez D; Instituto de Biología Molecular y Celular de Plantas, Consejo Superior de Investigaciones Científicas - Universitat Politècnica de València, Valencia, Spain.
Rodrigo G; Institute for Integrative Systems Biology, Consejo Superior de Investigaciones Científicas - Universitat de València, Paterna, Spain.
Geller R; Institute for Integrative Systems Biology, Consejo Superior de Investigaciones Científicas - Universitat de València, Paterna, Spain.
Daròs JA; Instituto de Biología Molecular y Celular de Plantas, Consejo Superior de Investigaciones Científicas - Universitat Politècnica de València, Valencia, Spain.
Pokaż więcej
Źródło:
Plant biotechnology journal [Plant Biotechnol J] 2024 Apr; Vol. 22 (4), pp. 876-891. Date of Electronic Publication: 2023 Nov 15.
Typ publikacji:
Journal Article
MeSH Terms:
Single-Domain Antibodies*/genetics
COVID-19*/genetics
Plant Viruses*
Nanoparticles*/chemistry
Spike Glycoprotein, Coronavirus*
Humans ; SARS-CoV-2/genetics ; SARS-CoV-2/metabolism ; Antibodies, Neutralizing ; Antibodies, Viral
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Predicting Natural Evolution in the RBD Region of the Spike Glycoprotein of SARS-CoV-2 by Machine Learning.
Autorzy:
Liu Y; College of Life Science and Technology, Beijing University of Chemical Technology, Beijing 100029, China.
He Z; College of International Education, Beijing University of Chemical Technology, Beijing 100029, China.
Jia L; College of International Education, Beijing University of Chemical Technology, Beijing 100029, China.
Xue Y; College of International Education, Beijing University of Chemical Technology, Beijing 100029, China.
Du Y; College of International Education, Beijing University of Chemical Technology, Beijing 100029, China.
Tan H; College of International Education, Beijing University of Chemical Technology, Beijing 100029, China.
Zhang X; College of Information Science and Technology, Beijing University of Chemical Technology, Beijing 100029, China.
Ji Y; College of Life Science and Technology, Beijing University of Chemical Technology, Beijing 100029, China.
Tong Y; College of Life Science and Technology, Beijing University of Chemical Technology, Beijing 100029, China.
Xu H; College of Mathematics and Physics, Beijing University of Chemical Technology, Beijing 100029, China.
Liu L; College of Life Science and Technology, Beijing University of Chemical Technology, Beijing 100029, China.
Pokaż więcej
Źródło:
Viruses [Viruses] 2024 Mar 20; Vol. 16 (3). Date of Electronic Publication: 2024 Mar 20.
Typ publikacji:
Journal Article
MeSH Terms:
Spike Glycoprotein, Coronavirus*/genetics
COVID-19*
Humans ; Prospective Studies ; SARS-CoV-2/genetics ; Machine Learning ; Mutation ; Glycoproteins ; Protein Binding
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Differential Mitochondrial, Oxidative Stress and Inflammatory Responses to SARS-CoV-2 Spike Protein Receptor Binding Domain in Human Lung Microvascular, Coronary Artery Endothelial and Bronchial Epithelial Cells.
Autorzy:
Kulkovienė G; Department of Drug Chemistry, Pharmacy Faculty, Lithuanian University of Health Sciences, 50162 Kaunas, Lithuania.
Narauskaitė D; Preclinical Research Laboratory for Medicinal Products, Institute of Cardiology, Lithuanian University of Health Sciences, 50162 Kaunas, Lithuania.
Tunaitytė A; Preclinical Research Laboratory for Medicinal Products, Institute of Cardiology, Lithuanian University of Health Sciences, 50162 Kaunas, Lithuania.
Volkevičiūtė A; Preclinical Research Laboratory for Medicinal Products, Institute of Cardiology, Lithuanian University of Health Sciences, 50162 Kaunas, Lithuania.
Balion Z; Preclinical Research Laboratory for Medicinal Products, Institute of Cardiology, Lithuanian University of Health Sciences, 50162 Kaunas, Lithuania.
Kutakh O; Preclinical Research Laboratory for Medicinal Products, Institute of Cardiology, Lithuanian University of Health Sciences, 50162 Kaunas, Lithuania.
Gečys D; Institute of Pharmaceutical Technologies, Faculty of Pharmacy, Lithuanian University of Health Sciences, 50162 Kaunas, Lithuania.; Laboratory of Molecular Cardiology, Institute of Cardiology, Lithuanian University of Health Sciences, 50162 Kaunas, Lithuania.
Kairytė M; Preclinical Research Laboratory for Medicinal Products, Institute of Cardiology, Lithuanian University of Health Sciences, 50162 Kaunas, Lithuania.
Uldukytė M; Preclinical Research Laboratory for Medicinal Products, Institute of Cardiology, Lithuanian University of Health Sciences, 50162 Kaunas, Lithuania.
Stankevičius E; Preclinical Research Laboratory for Medicinal Products, Institute of Cardiology, Lithuanian University of Health Sciences, 50162 Kaunas, Lithuania.
Jekabsone A; Preclinical Research Laboratory for Medicinal Products, Institute of Cardiology, Lithuanian University of Health Sciences, 50162 Kaunas, Lithuania.; Institute of Pharmaceutical Technologies, Faculty of Pharmacy, Lithuanian University of Health Sciences, 50162 Kaunas, Lithuania.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2024 Mar 10; Vol. 25 (6). Date of Electronic Publication: 2024 Mar 10.
Typ publikacji:
Journal Article
MeSH Terms:
Spike Glycoprotein, Coronavirus*
COVID-19*
Humans ; Coronary Vessels ; Reactive Oxygen Species ; SARS-CoV-2 ; Epithelial Cells ; Cytokines ; Oxidative Stress
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Nitrite Attenuates the In Vitro Inflammatory Response of Immune Cells to the SARS-CoV-2 S Protein without Interfering in the Antioxidant Enzyme Activation.
Autorzy:
Ferrer MD; Research Group on Community Nutrition and Oxidative Stress, University of Balearic Islands-IUNICS, 07122 Palma, Spain.; Health Research Institute of Balearic Islands (IdISBa), 07120 Palma, Spain.
Reynés C; Research Group on Community Nutrition and Oxidative Stress, University of Balearic Islands-IUNICS, 07122 Palma, Spain.
Jiménez L; Research Group on Community Nutrition and Oxidative Stress, University of Balearic Islands-IUNICS, 07122 Palma, Spain.
Malagraba G; Research Group on Community Nutrition and Oxidative Stress, University of Balearic Islands-IUNICS, 07122 Palma, Spain.
Monserrat-Mesquida M; Research Group on Community Nutrition and Oxidative Stress, University of Balearic Islands-IUNICS, 07122 Palma, Spain.; Health Research Institute of Balearic Islands (IdISBa), 07120 Palma, Spain.; Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Institute of Health Carlos III, 28029 Madrid, Spain.
Bouzas C; Research Group on Community Nutrition and Oxidative Stress, University of Balearic Islands-IUNICS, 07122 Palma, Spain.; Health Research Institute of Balearic Islands (IdISBa), 07120 Palma, Spain.; Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Institute of Health Carlos III, 28029 Madrid, Spain.
Sureda A; Research Group on Community Nutrition and Oxidative Stress, University of Balearic Islands-IUNICS, 07122 Palma, Spain.; Health Research Institute of Balearic Islands (IdISBa), 07120 Palma, Spain.; Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Institute of Health Carlos III, 28029 Madrid, Spain.
Tur JA; Research Group on Community Nutrition and Oxidative Stress, University of Balearic Islands-IUNICS, 07122 Palma, Spain.; Health Research Institute of Balearic Islands (IdISBa), 07120 Palma, Spain.; Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Institute of Health Carlos III, 28029 Madrid, Spain.
Pons A; Research Group on Community Nutrition and Oxidative Stress, University of Balearic Islands-IUNICS, 07122 Palma, Spain.; Health Research Institute of Balearic Islands (IdISBa), 07120 Palma, Spain.; Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Institute of Health Carlos III, 28029 Madrid, Spain.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2024 Mar 05; Vol. 25 (5). Date of Electronic Publication: 2024 Mar 05.
Typ publikacji:
Journal Article
MeSH Terms:
Metabolic Syndrome*
COVID-19*
Spike Glycoprotein, Coronavirus*
Humans ; Lipopolysaccharides/pharmacology ; Nitrites ; Antioxidants/metabolism ; Leukocytes, Mononuclear/metabolism ; Enzyme Activation ; Toll-Like Receptor 4/metabolism ; SARS-CoV-2/metabolism ; Cytokines/metabolism ; Anti-Inflammatory Agents
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Immunogenicity and safety of RAZI recombinant spike protein vaccine (RCP) as a booster dose after priming with BBIBP-CorV: a parallel two groups, randomized, double blind trial.
Autorzy:
Erfanpoor S; School of Public Health, Department of Epidemiology, Iran University of Medical Science, Tehran, Iran.
Banihashemi SR; Department of Immunology, Agricultural Research, Education and Extension Organization (AREEO), Razi Vaccine and Serum Research Institute, Karaj, Iran.
Mokhbaeralsafa L; Department of Epidemiology, Razi Vaccine and Serum Research Institute, Agricultural Research, Education and Extension Organization (AREEO), Karaj, Iran.
Kalantari S; Departments of Infectious Diseases and Tropical Medicine, Iran University of Medical Sciences, Tehran, Iran.
Es-Haghi A; Department of Physico Chemistry, Razi Vaccine and Serum Research Institute, Agricultural Research, Education and Extension Organization (AREEO), Karaj, Iran.
Nofeli M; Department of Research and Development, Razi Vaccine and Serum Research Institute, Agricultural Research, Education and Extension Organization (AREEO), Karaj, Iran.
Rezaei Mokarram A; Department of QA, Razi Vaccine and Serum Research Institute, Agricultural Research, Education and Extension Organization (AREEO), Karaj, Iran.
Sadeghi F; Department of QA, Razi Vaccine and Serum Research Institute, Agricultural Research, Education and Extension Organization (AREEO), Karaj, Iran.
Hajimoradi M; Department of Immunology, Agricultural Research, Education and Extension Organization (AREEO), Razi Vaccine and Serum Research Institute, Karaj, Iran.
Razaz SH; Department of Immunology, Agricultural Research, Education and Extension Organization (AREEO), Razi Vaccine and Serum Research Institute, Karaj, Iran.
Taghdiri M; Department of Immunology, Agricultural Research, Education and Extension Organization (AREEO), Razi Vaccine and Serum Research Institute, Karaj, Iran.
Lotfi M; Department of Quality Control, Razi Vaccine and Serum Research Institute, Agricultural Research, Education and Extension Organization (AREEO), Karaj, Iran.
Khorasani A; Department of Research and Development, Razi Vaccine and Serum Research Institute, Agricultural Research, Education and Extension Organization (AREEO), Karaj, Iran.
Ansarifar A; School of Public Health, Department of Epidemiology, Iran University of Medical Science, Tehran, Iran.
Masoumi S; Department of Biostatistics, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.
Mohazzab A; School of Public Health, Department of Epidemiology, Iran University of Medical Science, Tehran, Iran.; Reproductive Biotechnology Research Center, Avicenna Research Institute Tehran, ACECR, Tehran, Iran.
Filsoof S; School of Medicine, Iran University of Medical Science, Tehran, Iran.
Mohseni V; School of Public Health, Department of Epidemiology, Iran University of Medical Science, Tehran, Iran.
Shahsavan M; School of Public Health, Department of Epidemiology, Iran University of Medical Science, Tehran, Iran.
Gharavi N; School of Medicine, Iran University of Medical Science, Tehran, Iran.
Setarehdan SA; School of Public Health, Department of Epidemiology, Iran University of Medical Science, Tehran, Iran.; Minimally Invasive Surgery Research Center, Hazrat-E-Rasool Hospital, Iran University of Medical Science, Tehran, Iran.
Rabiee MH; Division of Epidemiology, Faculty of Veterinary Medicine, University of Tehran, Tehran, Iran.
Fallah Mehrabadi MH; Department of Epidemiology, Razi Vaccine and Serum Research Institute, Agricultural Research, Education and Extension Organization (AREEO), Karaj, Iran. .
Solaymani-Dodaran M; Minimally Invasive Surgery Research Center, Hazrat-E-Rasool Hospital, Iran University of Medical Science, Tehran, Iran. .; Clinical Trial Center, Iran University of Medical Science, Tehran, Iran. .; Division of Epidemiology and Public Health, University of Nottingham, Nottingham, NG7 2UH, UK. .
Pokaż więcej
Źródło:
BMC medicine [BMC Med] 2024 Feb 20; Vol. 22 (1), pp. 78. Date of Electronic Publication: 2024 Feb 20.
Typ publikacji:
Randomized Controlled Trial; Journal Article
MeSH Terms:
COVID-19 Vaccines*/adverse effects
Spike Glycoprotein, Coronavirus*
Vaccines, Inactivated*
Adult ; Male ; Humans ; Adolescent ; Middle Aged ; Female ; Iran ; Antibodies, Neutralizing ; Antibodies, Viral
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Analysis of the transplacental transmission of SARS CoV-2 virus and antibody transfer according to the gestational age at maternal infection.
Autorzy:
Lucot-Royer L; Pôle Mère-Femme, Department of Obstetrics and Gynecology, University Hospital of Besancon, University of Franche-Comte, Alexander Fleming Boulevard, 25000, Besançon, France.
Nallet C; Pôle Mère-Femme, Department of Obstetrics and Gynecology, University Hospital of Besancon, University of Franche-Comte, Alexander Fleming Boulevard, 25000, Besançon, France.
Vouga M; Pôle Mère-Femme, Department of Obstetrics and Gynecology, University Hospital of Besancon, University of Franche-Comte, Alexander Fleming Boulevard, 25000, Besançon, France.
Puyraveau M; Pôle Mère-Femme, Department of Obstetrics and Gynecology, University Hospital of Besancon, University of Franche-Comte, Alexander Fleming Boulevard, 25000, Besançon, France.
Mauny F; Pôle Mère-Femme, Department of Obstetrics and Gynecology, University Hospital of Besancon, University of Franche-Comte, Alexander Fleming Boulevard, 25000, Besançon, France.
Marty-Quinternet S; Nanomedicine Lab, Imagery and Therapeutics, EA4662, University of Franche-Comte, 25000, Besançoon, France.
Bertholdt C; Department of Obstetrics and Gynecology, University Hospital of Nancy, Nancy Hopital Central, 54000, Nancy, France.
Bory JP; Department of Obstetrics and Gynecology, University Hospital of Reims, 51092, Reims, France.
Devalland C; Department of Obstetrics and Gynecology, Hopital Nord Franche Comté, 90400, Trévenans, France.
Canaguier M; Department of Obstetrics and Gynecology, Hopital Nord Franche Comté, 90400, Trévenans, France.
Copolla C; Department of Obstetrics and Gynecology, Groupe Hospitalier de la Haute-Saone, 70000, Vesoul, France.
Eszto ML; Department of Obstetrics and Gynecology, CHR Metz-Thionville, 57100, Thionville, France.
Montoya Y; Department of Obstetrics and Gynecology, CHR Metz-Thionville, 57100, Thionville, France.
Roesch M; Department of Obstetrics and Gynecology, CHR Metz-Thionville, 57100, Thionville, France.
Reviron S; Department of Obstetrics and Gynecology, Hopital Jura Sud, 39000, Lons-Le-Saunier, France.
Riethmuller D; Department of Obstetrics and Gynecology, University Hospital of Grenoble, CHU Grenoble Alpes, 38700, La Tronche, France.
Rufenacht E; Department of Obstetrics and Gynecology, Centre Hospitalier Intercommunal de Haute Comté, 25300, Pontarlier, France.
Simon E; Department of Obstetrics and Gynecology, University Hospital of Dijon, CHU Mitterand, 21000, Dijon, France.
Mottet N; Pôle Mère-Femme, Department of Obstetrics and Gynecology, University Hospital of Besancon, University of Franche-Comte, Alexander Fleming Boulevard, 25000, Besançon, France. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Feb 11; Vol. 14 (1), pp. 3458. Date of Electronic Publication: 2024 Feb 11.
Typ publikacji:
Observational Study; Multicenter Study; Journal Article
MeSH Terms:
COVID-19*
Pregnancy Complications, Infectious*
Spike Glycoprotein, Coronavirus*
Female ; Humans ; Infant, Newborn ; Pregnancy ; Antibodies, Viral ; Gestational Age ; Immunoglobulin G ; Mothers ; Placenta ; SARS-CoV-2
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
SARS-CoV-2 Infection Alters the Phenotype and Gene Expression of Adipocytes.
Autorzy:
Quaranta P; Retrovirus Center, Virology Section, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Via Savi 10, 56126 Pisa, Italy.; National Research Council-Institute of Neuroscience, Via Moruzzi 1, 56124 Pisa, Italy.
Scabia G; National Research Council-Institute of Clinical Physiology, Via Moruzzi 1, 56124 Pisa, Italy.; Center for Obesity and Lipodystrophy, Pisa University-Hospital, Via Paradisa 2, 56124 Pisa, Italy.
Storti B; National Enterprise for nanoScience and nanoTechnology, Scuola Normale Superiore, National Research Council-Institute of Nanoscience, Piazza San Silvestro 12, 56127 Pisa, Italy.
Dattilo A; Center for Obesity and Lipodystrophy, Pisa University-Hospital, Via Paradisa 2, 56124 Pisa, Italy.
Quintino L; National Research Council-Institute of Clinical Physiology, Via Moruzzi 1, 56124 Pisa, Italy.
Perrera P; Retrovirus Center, Virology Section, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Via Savi 10, 56126 Pisa, Italy.
Di Primio C; National Research Council-Institute of Neuroscience, Via Moruzzi 1, 56124 Pisa, Italy.
Costa M; National Research Council-Institute of Neuroscience, Via Moruzzi 1, 56124 Pisa, Italy.
Pistello M; Retrovirus Center, Virology Section, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Via Savi 10, 56126 Pisa, Italy.; Virology Unit, Pisa University-Hospital, Via Paradisa 2, 56124 Pisa, Italy.
Bizzarri R; National Enterprise for nanoScience and nanoTechnology, Scuola Normale Superiore, National Research Council-Institute of Nanoscience, Piazza San Silvestro 12, 56127 Pisa, Italy.; Department of Surgical, Medical and Molecular Pathology, and Critical Care Medicine, University of Pisa, Via Roma 65, 56126 Pisa, Italy.
Maffei M; National Research Council-Institute of Clinical Physiology, Via Moruzzi 1, 56124 Pisa, Italy.; Center for Obesity and Lipodystrophy, Pisa University-Hospital, Via Paradisa 2, 56124 Pisa, Italy.; Italian National Institute for Nuclear Physics, Via Filippo Buonarroti 3, 56127 Pisa, Italy.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2024 Feb 08; Vol. 25 (4). Date of Electronic Publication: 2024 Feb 08.
Typ publikacji:
Journal Article
MeSH Terms:
Spike Glycoprotein, Coronavirus*/metabolism
COVID-19*/metabolism
Intellectual Disability*
Heart Defects, Congenital*
Genetic Diseases, X-Linked*
Gigantism*
Arrhythmias, Cardiac*
Humans ; Cells, Cultured ; SARS-CoV-2 ; Adipocytes/metabolism ; Phenotype ; Gene Expression
SCR Disease Name:
Simpson-Golabi-Behmel syndrome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Differential Ability of Spike Protein of SARS-CoV-2 Variants to Downregulate ACE2.
Autorzy:
Maeda Y; Department of Microbiology, Faculty of Life Sciences, Kumamoto University, Kumamoto 860-8556, Japan.
Toyoda M; Joint Research Center for Human Retrovirus Infection, Kumamoto University, Kumamoto 860-0811, Japan.
Kuwata T; Joint Research Center for Human Retrovirus Infection, Kumamoto University, Kumamoto 860-0811, Japan.
Terasawa H; Department of Microbiology, Faculty of Life Sciences, Kumamoto University, Kumamoto 860-8556, Japan.
Tokugawa U; Department of Microbiology, Faculty of Life Sciences, Kumamoto University, Kumamoto 860-8556, Japan.
Monde K; Department of Microbiology, Faculty of Life Sciences, Kumamoto University, Kumamoto 860-8556, Japan.
Sawa T; Department of Microbiology, Faculty of Life Sciences, Kumamoto University, Kumamoto 860-8556, Japan.
Ueno T; Joint Research Center for Human Retrovirus Infection, Kumamoto University, Kumamoto 860-0811, Japan.
Matsushita S; Joint Research Center for Human Retrovirus Infection, Kumamoto University, Kumamoto 860-0811, Japan.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2024 Jan 22; Vol. 25 (2). Date of Electronic Publication: 2024 Jan 22.
Typ publikacji:
Journal Article
MeSH Terms:
Angiotensin-Converting Enzyme 2*/metabolism
SARS-CoV-2*/metabolism
Spike Glycoprotein, Coronavirus*/metabolism
Humans ; COVID-19/metabolism ; COVID-19/virology ; Mutation ; Protein Binding
SCR Organism:
SARS-CoV-2 variants
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
PandoGen: Generating complete instances of future SARS-CoV-2 sequences using Deep Learning.
Autorzy:
Ramachandran A; University of Illinois at Urbana-Champaign, Urbana, Illinois, United States of America.
Lumetta SS; University of Illinois at Urbana-Champaign, Urbana, Illinois, United States of America.
Chen D; University of Illinois at Urbana-Champaign, Urbana, Illinois, United States of America.
Pokaż więcej
Źródło:
PLoS computational biology [PLoS Comput Biol] 2024 Jan 19; Vol. 20 (1), pp. e1011790. Date of Electronic Publication: 2024 Jan 19 (Print Publication: 2024).
Typ publikacji:
Journal Article
MeSH Terms:
COVID-19*/epidemiology
Deep Learning*
Spike Glycoprotein, Coronavirus*
Humans ; SARS-CoV-2/genetics ; Amino Acid Sequence
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Anti-SARS-CoV-2-specific antibodies in human breast milk following SARS-CoV-2 infection during pregnancy: a prospective cohort study.
Autorzy:
Fernández-Buhigas I; Obstetrics and Gynecology Department, Hospital Universitario de Torrejón, Torrejón de Ardoz, Madrid, Spain.; Vicerrectorado de Investigación, Facultad de Medicina, Universidad Francisco de Vitoria, Carretera Pozuelo a Majadahonda, Km 1.800, Pozuelo de Alarcón, Madrid, 28223, Spain.
Rayo N; Obstetrics and Gynecology Department, Hospital Universitario de Torrejón, Torrejón de Ardoz, Madrid, Spain.; Vicerrectorado de Investigación, Facultad de Medicina, Universidad Francisco de Vitoria, Carretera Pozuelo a Majadahonda, Km 1.800, Pozuelo de Alarcón, Madrid, 28223, Spain.
Silos JC; Synlab Diagnósticos Globales S.A., Esplugues de Llobregat, Catalonia, Spain.
Serrano B; Department of Obstetrics, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Catalonia, Spain.
Ocón-Hernández O; Obstetrics and Gynecology Department, Hospital Universitario Clínico San Cecilio, Granada, Spain.; Instituto de Investigación Biosanitaria Ibs, Granada, Spain.
Leung BW; Department of Obstetrics and Gynaecology, The Chinese University of Hong Kong, Hong Kong SAR, China.
Delgado JL; Obstetrics and Gynecology Department, Hospital Clínico Universitario Virgen de La Arrixaca, El Palmar, Murcia, Spain.
Fernández DS; Obstetrics and Gynecology Department, Hospital Universitário Príncipe de Asturias, Alcalá de Henares, Madrid, Spain.; Universidad de Alcalá de Henares, School of Medicine, Alcalá de Henares, Madrid, Spain.
Valle S; Obstetrics and Gynecology Department, Hospital Universitario de Torrejón, Torrejón de Ardoz, Madrid, Spain.; Vicerrectorado de Investigación, Facultad de Medicina, Universidad Francisco de Vitoria, Carretera Pozuelo a Majadahonda, Km 1.800, Pozuelo de Alarcón, Madrid, 28223, Spain.
De Miguel L; Synlab Diagnósticos Globales S.A., Esplugues de Llobregat, Catalonia, Spain.
Silgado A; Department of Microbiology, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Catalonia, Spain.
Tanoira RP; Department of Microbiology, Hospital Universitário Príncipe de Asturias, Alcalá de Henares, Madrid, Spain.
Rolle V; Biostatistics and Epidemiology Platform at Instituto de Investigación Sanitaria del Principado de Asturias, Oviedo, Asturias, Spain.
Santacruz B; Obstetrics and Gynecology Department, Hospital Universitario de Torrejón, Torrejón de Ardoz, Madrid, Spain.; Vicerrectorado de Investigación, Facultad de Medicina, Universidad Francisco de Vitoria, Carretera Pozuelo a Majadahonda, Km 1.800, Pozuelo de Alarcón, Madrid, 28223, Spain.
Gil MM; Obstetrics and Gynecology Department, Hospital Universitario de Torrejón, Torrejón de Ardoz, Madrid, Spain. .; Vicerrectorado de Investigación, Facultad de Medicina, Universidad Francisco de Vitoria, Carretera Pozuelo a Majadahonda, Km 1.800, Pozuelo de Alarcón, Madrid, 28223, Spain. .
Poon LC; Department of Obstetrics and Gynaecology, The Chinese University of Hong Kong, Hong Kong SAR, China. .
Pokaż więcej
Źródło:
International breastfeeding journal [Int Breastfeed J] 2024 Jan 18; Vol. 19 (1), pp. 5. Date of Electronic Publication: 2024 Jan 18.
Typ publikacji:
Journal Article
MeSH Terms:
COVID-19*
Pregnancy Complications, Infectious*
Spike Glycoprotein, Coronavirus*
Humans ; Female ; Pregnancy ; Milk, Human/chemistry ; Breast Feeding ; Prospective Studies ; SARS-CoV-2 ; Antibodies, Viral/analysis ; Immunoglobulin A/analysis
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
SARS-CoV-2 S protein activates NLRP3 inflammasome and deregulates coagulation factors in endothelial and immune cells.
Autorzy:
Villacampa A; Department of Pharmacology, School of Medicine, Universidad Autónoma de Madrid, Madrid, Spain.
Alfaro E; Respiratory Diseases Group, Respiratory Service, La Paz University Hospital, IdiPAZ, Madrid, Spain.; Biomedical Research Networking Center on Respiratory Diseases (CIBERES), Madrid, Spain.
Morales C; Department of Pharmacology, School of Medicine, Universidad Autónoma de Madrid, Madrid, Spain.
Díaz-García E; Respiratory Diseases Group, Respiratory Service, La Paz University Hospital, IdiPAZ, Madrid, Spain.; Biomedical Research Networking Center on Respiratory Diseases (CIBERES), Madrid, Spain.
López-Fernández C; Respiratory Diseases Group, Respiratory Service, La Paz University Hospital, IdiPAZ, Madrid, Spain.
Bartha JL; Department of Obstetrics and Gynecology, School of Medicine, Universidad Autónoma de Madrid, Madrid, Spain.; Gynecology and Obstetrics Service, La Paz University Hospital, Madrid, Spain.
López-Sánchez F; Gynecology and Obstetrics Service, La Paz University Hospital, Madrid, Spain.
Lorenzo Ó; Laboratory of Diabetes and Vascular pathology, IIS-Fundación Jiménez Díaz, Madrid, Spain.; Biomedical Research Networking Centre on Diabetes and Associated Metabolic Disorders (CIBERDEM), Madrid, Spain.; Department of Medicine, School of Medicine, Universidad Autónoma de Madrid, Madrid, Spain.
Moncada S; Department of Pharmacology, School of Medicine, Universidad Autónoma de Madrid, Madrid, Spain.
Sánchez-Ferrer CF; Department of Pharmacology, School of Medicine, Universidad Autónoma de Madrid, Madrid, Spain.; Vascular Pharmacology and Metabolism (FARMAVASM) group, IdiPAZ, Madrid, Spain.
García-Río F; Respiratory Diseases Group, Respiratory Service, La Paz University Hospital, IdiPAZ, Madrid, Spain.; Biomedical Research Networking Center on Respiratory Diseases (CIBERES), Madrid, Spain.; Department of Medicine, School of Medicine, Universidad Autónoma de Madrid, Madrid, Spain.
Cubillos-Zapata C; Respiratory Diseases Group, Respiratory Service, La Paz University Hospital, IdiPAZ, Madrid, Spain. .; Biomedical Research Networking Center on Respiratory Diseases (CIBERES), Madrid, Spain. .
Peiró C; Department of Pharmacology, School of Medicine, Universidad Autónoma de Madrid, Madrid, Spain. .; Vascular Pharmacology and Metabolism (FARMAVASM) group, IdiPAZ, Madrid, Spain. .
Pokaż więcej
Źródło:
Cell communication and signaling : CCS [Cell Commun Signal] 2024 Jan 15; Vol. 22 (1), pp. 38. Date of Electronic Publication: 2024 Jan 15.
Typ publikacji:
Video-Audio Media; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Inflammasomes*/metabolism
COVID-19*
Spike Glycoprotein, Coronavirus*
Humans ; NLR Family, Pyrin Domain-Containing 3 Protein/metabolism ; COVID-19 Vaccines ; NF-kappa B/metabolism ; von Willebrand Factor ; SARS-CoV-2 ; Human Umbilical Vein Endothelial Cells/metabolism ; Interleukin-1beta/metabolism
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Incidence and Severity of COVID-19 in Relation to Anti-Receptor-Binding Domain IgG Antibody Level after COVID-19 Vaccination in Kidney Transplant Recipients.
Autorzy:
Messchendorp AL; Department of Nephrology, University Medical Center Groningen, University of Groningen, 9713 GZ Groningen, The Netherlands.
Sanders JF; Department of Nephrology, University Medical Center Groningen, University of Groningen, 9713 GZ Groningen, The Netherlands.
Abrahams AC; Department of Nephrology and Hypertension, University Medical Center Utrecht, 3508 GA Utrecht, The Netherlands.
Bemelman FJ; Division of Nephrology, Department of Internal Medicine, Amsterdam University Medical Center, Location Amsterdam Medical Center, 1105 AZ Amsterdam, The Netherlands.
Bouwmans P; Department of Internal Medicine, Division of Nephrology, Maastricht University Medical Center, 6229 HX Maastricht, The Netherlands.; CARIM School for Cardiovascular Disease, University of Maastricht, 6211 LK Maastricht, The Netherlands.
van den Dorpel RMA; Department of Nephrology, Maasstad Hospital, 3079 DZ Rotterdam, The Netherlands.
Hilbrands LB; Department of Nephrology, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands.
Imhof C; Department of Nephrology, University Medical Center Groningen, University of Groningen, 9713 GZ Groningen, The Netherlands.
Reinders MEJ; Erasmus MC Transplant Institute, Nephrology and Transplantation, Department of Internal Medicine, University Medical Center Rotterdam, 3015 GD Rotterdam, The Netherlands.
Rispens T; Department of Immunopathology, Sanquin Research, 1006 AD Amsterdam, The Netherlands.; Landsteiner Laboratory, Amsterdam University Medical Center, University of Amsterdam, 1012 WP Amsterdam, The Netherlands.
Steenhuis M; Department of Immunopathology, Sanquin Research, 1006 AD Amsterdam, The Netherlands.; Landsteiner Laboratory, Amsterdam University Medical Center, University of Amsterdam, 1012 WP Amsterdam, The Netherlands.
Ten Dam MAGJ; Department of Internal Medicine, Canisius Wilhelmina Hospital, 6532 SZ Nijmegen, The Netherlands.
Vart P; Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, 9713 GZ Groningen, The Netherlands.
de Vries APJ; Leiden University Medical Center, Department of Nephrology and Leiden Transplant Center, 2333 ZA Leiden, The Netherlands.
Hemmelder MH; Department of Internal Medicine, Division of Nephrology, Maastricht University Medical Center, 6229 HX Maastricht, The Netherlands.
Gansevoort RT; Department of Nephrology, University Medical Center Groningen, University of Groningen, 9713 GZ Groningen, The Netherlands.
Recovac Investigators
Pokaż więcej
Źródło:
Viruses [Viruses] 2024 Jan 12; Vol. 16 (1). Date of Electronic Publication: 2024 Jan 12.
Typ publikacji:
Journal Article
MeSH Terms:
COVID-19*/epidemiology
COVID-19*/prevention & control
Kidney Transplantation*
Spike Glycoprotein, Coronavirus*
Humans ; Incidence ; COVID-19 Vaccines ; SARS-CoV-2 ; Immunoglobulin G
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Site-Specific O-glycosylation of SARS-CoV-2 Spike Protein and Its Impact on Immune and Autoimmune Responses.
Autorzy:
Hanisch FG; Center of Biochemistry, Medical Faculty, University of Cologne, Joseph-Stelzmann-Str. 52, 50931 Cologne, Germany.
Pokaż więcej
Źródło:
Cells [Cells] 2024 Jan 05; Vol. 13 (2). Date of Electronic Publication: 2024 Jan 05.
Typ publikacji:
Journal Article; Review
MeSH Terms:
COVID-19*/immunology
COVID-19*/metabolism
SARS-CoV-2*/chemistry
SARS-CoV-2*/metabolism
Spike Glycoprotein, Coronavirus*/metabolism
Humans ; Autoimmunity ; Glycosylation ; Pandemics ; Polysaccharides
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
In-silico evaluation of natural alkaloids against the main protease and spike glycoprotein as potential therapeutic agents for SARS-CoV-2.
Autorzy:
Shah M; Department of Biochemistry, Bahauddin Zakariya University, Multan, Pakistan.
Yamin R; Department of Biochemistry, Bahauddin Zakariya University, Multan, Pakistan.
Ahmad I; Department of Biochemistry, Bahauddin Zakariya University, Multan, Pakistan.
Wu G; Department of Infectious Diseases, The Affiliated Hospital of Southwest Medical University, Luzhou, China.
Jahangir Z; Department of Computer Science, University of Agriculture Faisalabad, Punjab, Pakistan.
Shamim A; Department of Computer Science, University of Agriculture Faisalabad, Punjab, Pakistan.
Nawaz H; Department of Biochemistry, Bahauddin Zakariya University, Multan, Pakistan.
Nishan U; Department of Chemistry, Kohat University of Science & Technology, Kohat, Pakistan.
Ullah R; Department of Pharmacognosy, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.
Ali EA; Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.
Sheheryar; Department of Biochemistry and Molecular Biology, Federal University of Ceara, Fortaleza, Brazil.
Chen K; Department of Infectious Diseases, The Affiliated Hospital of Southwest Medical University, Luzhou, China.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2024 Jan 04; Vol. 19 (1), pp. e0294769. Date of Electronic Publication: 2024 Jan 04 (Print Publication: 2024).
Typ publikacji:
Journal Article
MeSH Terms:
Alkaloids*/pharmacology
Antiviral Agents*/pharmacology
Protease Inhibitors*/pharmacology
SARS-CoV-2*/drug effects
Spike Glycoprotein, Coronavirus*/antagonists & inhibitors
Humans ; COVID-19 ; Emetine ; Molecular Docking Simulation ; Molecular Dynamics Simulation ; Peptide Hydrolases
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Discovery and development of COVID-19 vaccines and therapeutics: nonclinical perspectives.
Autorzy:
Khan N; Pfizer Research and Development, Pfizer Inc, Groton, CT, USA.
Sathish J; Pfizer Research and Development, Pfizer Inc, Pearl River, NY, USA.
Rohde CM; Pfizer Research and Development, Pfizer Inc, Pearl River, NY, USA.
Pokaż więcej
Źródło:
The Journal of toxicological sciences [J Toxicol Sci] 2024; Vol. 49 (3), pp. 79-94.
Typ publikacji:
Journal Article
MeSH Terms:
COVID-19 Vaccines*
COVID-19*/prevention & control
Spike Glycoprotein, Coronavirus*
Humans ; BNT162 Vaccine ; SARS-CoV-2 ; Indoles
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Wyświetlanie 1-20 z 2209

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies